The 2024 AHA Kawasaki disease statement. It highlights the need for a formal transition program for adolescents and adults with KD. Patients with giant aneurysms remain at high risk for heart attack and require lifelong monitoring and care”.
https://t.co/2i1hoBHWi8
👶Excellent neonatal #WhyCMR case being published 4/3/25 Cases of @SCMRorg
📺Tune in on Thursday to find out the dx and how this patient was managed.
#SCMRCases
IKDR members at @American_Heart moderating #KD session, debating the need for long term follow up in children with small CAA and presenting on thrombocytosis in #KD and #MISC
The 2024 AHA Kawasaki disease statement. It highlights the need for a formal transition program for adolescents and adults with KD. Patients with giant aneurysms remain at high risk for heart attack and require lifelong monitoring and care”.
https://t.co/2i1hoBHWi8
Early #diagnosis & treatment is 🔑 if the risk of lifelong #heart damage is to be reduced. Today it is little known - but EVERY parent and EVERY doctor needs to know #Kawasaki_Disease - if we are to protect children’s ❤ and prevent lifelong #heartdisease in our children.
@IKDregistry@DrNChoueiter It was a first step in an amazingly promising journey to come. When 12+ countries represented by 20+ academic medical institutions work hand in hand for a common cause, improving children's health morbidities related to an orphan disease, you can just imagine countless magic!!!
KD was first reported in Japan in 1967 yet it has been described worldwide . Today we had our first meeting discussing a KD pan Arab research initiative (kawarabi) that aims at understanding the manifestations of the disease in the Arab world.